Press release
Digital Opulence to Drive the Injectable Drug Delivery Market
The Injectable Drug Delivery Market is expected to go digital ways in the forecast period. With the non-linear journey of the healthcare vertical, personalization is looked upon as the key to effective healthcare. Furthermore, patient portals would be launched as well as refined. Mobile-friendliness would be taken into consideration. Treatment-specific information or recommendation of certain appointments or services would be personalized. This would be the healthcare vertical in the upcoming period.Over the years, there has been a rise in the demand for convenient and efficient drug delivery systems for patients that rely on prescription drugs on a regular basis. This creates a lucrative opportunity for pharmaceutical manufacturers all over the world to develop sophisticated, easy-to-use, and effective injectable drug delivery devices. Moreover, rise in the prevalence of chronic diseases such as diabetes, cancer, and rheumatoid arthritis are likely to fuel the growth of the injectable drug delivery market during the forecast period.
Strategizing The Moves For The Next Decade? See Through Sample Of Injectable Drug Delivery Market Report! https://www.persistencemarketresearch.com/samples/3774
The global injectable drug delivery market was valued at US$ 30.5 Bn in 2018, and is expected to exhibit a CAGR of around 9% during the forecast period (2019–2029).
Get a Customized Scope to Match Your Need Ask an Expert- sales@persistencemarketresearch.com
Company Profiles
Eli Lilly and Company
Biocon
Becton, Dickinson & Company
West Pharmaceutical Services, Inc.
Johnson & Johnson
Antares Pharma
AbbVie Inc.
Pfizer Inc.
Mylan N.V.
Vetter Pharma-Fertigung GmbH & Co.KG
Emperra GmbH
Starting With The New Decade On A Diligent Note In The Injectable Drug Delivery Market? https://www.persistencemarketresearch.com/methodology/3774
Key Takeaways of Injectable Drug Delivery Market Study
Insulin pens contributed the most share to the injectable drug delivery market in 2018, due to the rising prevalence of diabetes in developing countries.
Non-smart injector technology accounted for a prominent share in the global injectable drug delivery market in 2018, due to increase in the adoption of advanced technology and rising demand for smartphone-integrated products.
Rise in the demand for connected devices and the high cost of such devices offer growth opportunities for manufacturers of reusable injectable drug delivery devices.
Diabetes indication is expected to continue to hold a prominent position in the injectable drug delivery market throughout the forecast period.
Increase in the number of pharmaceutical manufacturers has contributed to the dominance of North America in the global injectable drug delivery market.
Attributed to growing awareness regarding various diseases such as cancer and diabetes, East Asia is expected to register notable growth opportunities for the injectable drug delivery market.
“Smart injectable drug delivery devices not only improve patient compliance to treatment but also collect extensive data that is valuable for future research. Rising demand for connected injectable drug delivery devices will offer significant growth opportunity for the injectable drug delivery market,” says a PMR analyst.
How About Obtaining Insights About The Region To Enter Concerning The Injectable Drug Delivery Market? Press The “Purchase Now” Button To Have Our Injectable Drug Delivery Market Report! https://www.persistencemarketresearch.com/checkout/3774
Trends in Smart Injectable Drug Delivery Technologies
There are many research and pipeline products that will have the ability to connect with smartphones and trackers. However, current smart products are predominantly available as reusable devices. This is attributed to the current state of technology that requires further advancements to apply to disposable products. According to a number of studies and key opinion leaders in the industry, there are a number of factors that limit disposable injectable drug delivery devices from being integrated with smart/connecting technologies. Some of these factors include high cost of Bluetooth integration, low range connectivity with NFC, and lack of power source for connectivity. Thus, although disposable injectable drug delivery will continue holding a larger share throughout the forecast period, reusable injectable drug delivery devices have the potential to grow at a relatively faster rate, at least in the first five years of the forecast period.
More Valuable Insights on Injectable Drug Delivery Market
Persistence Market Research offers a unique perspective and actionable insights on the injectable drug delivery market in its latest study. The report presents historical demand assessment of 2014–2018 and projections for 2019–2029, on the basis of product (self-injectors, needle-free injectors, auto injectors, wearable injectors, and insulin pens), technology (non-smart injectors and smart injectors), usage (disposable injectors and reusable injectors), indication (anaphylaxis, diabetes, cardiovascular diseases, multiple sclerosis, rheumatoid arthritis, cancer, trauma and emergency, and others), and distribution channel (hospital pharmacies, drug stores, retail pharmacies, and online pharmacies), across seven regions.
Complete Report Details@ https://www.persistencemarketresearch.com/market-research/injectable-drug-delivery-market.asp
Read More Trending "PMR Exclusive Article"-
U.S Bacterial Conjunctivitis Drugs Market@ https://www.persistencemarketresearch.com/market-research/u.s-bacterial-conjunctivitis-drugs-market.asp
Antibiotic Resistance Market@ https://www.persistencemarketresearch.com/market-research/antibiotic-resistance-market.asp
Contact us:
305 Broadway, 7th Floor
New York City, NY 10007 United States
Ph.no. +1-646-568-7751
E-mail id- sales@persistencemarketresearch.com
Website: https://www.persistencemarketresearch.com
About us-
Business intelligence is the foundation of every business model employed by Persistence Market Research. Multi-dimensional sources are being put to work, which include big data, customer experience analytics, and real-time data collection. Thus, working on “micros” by Persistence Market Research helps companies overcome their “macro” business challenges.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Digital Opulence to Drive the Injectable Drug Delivery Market here
News-ID: 2502043 • Views: …
More Releases from Persistence Market Research
Multiomics Market Set for Robust Expansion Driven by Precision Medicine - Persis …
The global multiomics market has entered a high-growth phase, driven by rapid advancements in high-throughput technologies, expanded clinical applications, and the accelerating shift toward precision medicine. According to recent industry assessments, the market was valued at US$2.1 Bn in 2023 and is expected to reach US$5.3 Bn by 2030, reflecting a powerful CAGR of 14.2%. This upward trajectory underscores how multiomics-integrating genomics, transcriptomics, proteomics, metabolomics, and epigenomics-is transforming biological research…
Migraine Nasal Spray Market Surges Toward US$ 790 Mn Valuation by 2032 - Persist …
The global migraine nasal spray market is entering a period of accelerated expansion as healthcare systems worldwide place increasing emphasis on rapid, non-invasive therapeutic solutions for neurological disorders. Migraine, a highly prevalent and debilitating condition that affects productivity, quality of life, and healthcare spending, is driving strong demand for nasal spray treatments that offer fast and targeted relief. Unlike oral medications, which may be delayed by gastrointestinal issues or reduced…
Eyelid Scrub Market to Reach US$6 Bn by 2032 with 7.2% CAGR - Persistence Market …
The global eyelid scrub market continues to gain momentum as eye hygiene becomes a central component of preventive healthcare. Valued at US$ 3.7 billion in 2025, the market is projected to reach US$ 6 billion by 2032, growing at a 7.2% CAGR. The surge in cases of blepharitis, dry eye syndrome, and digital eye strain has driven consumer awareness around eyelid cleanliness as a foundational step in eye health. Eyelid…
Uncomplicated Urinary Tract Infection (UTI) Treatment Market Driven by Rising In …
The global uncomplicated urinary tract infection (UTI) treatment market continues to gain remarkable momentum, supported by a growing patient pool, rising healthcare awareness, and ongoing pharmaceutical innovation. With a market value of US$6.09 billion in 2023, the sector is projected to reach US$11.9 billion by 2030, expanding at a robust CAGR of 10.3%. This strong growth trajectory reflects the persistent prevalence of UTIs-particularly among women-combined with the rising need for…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
